IDH2 and anaplastic astrocytoma: Among patients previously diagnosed as IDH-mutant GBM, anaplastic astrocytoma, or diffuse astrocytoma, 60 cases exhibited IDH1 or IDH2 mutations and were reclassified as A-IDHm.